110 related articles for article (PubMed ID: 11689076)
21. Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
Matralis AN; Kourounakis AP
J Med Chem; 2014 Mar; 57(6):2568-81. PubMed ID: 24568631
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of some N-benzhydrylpiperazine derivatives as calcium antagonists.
Gubert S; Brasó MA; Sacristán A; Ortiz JA
Arzneimittelforschung; 1987 Oct; 37(10):1103-7. PubMed ID: 3435581
[TBL] [Abstract][Full Text] [Related]
23. Effect of phytosterols on copper lipid peroxidation of human low-density lipoproteins.
Ferretti G; Bacchetti T; Masciangelo S; Bicchiega V
Nutrition; 2010 Mar; 26(3):296-304. PubMed ID: 19815390
[TBL] [Abstract][Full Text] [Related]
24. Lipid-soluble 3-pyridinol antioxidants spare alpha-tocopherol and do not efficiently mediate peroxidation of cholesterol esters in human low-density lipoprotein.
Kim HY; Pratt DA; Seal JR; Wijtmans M; Porter NA
J Med Chem; 2005 Nov; 48(22):6787-9. PubMed ID: 16250637
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of 4,6-di-tert-butyl-2,3-dihydro-5-benzofuranols as a novel series of antiatherogenic antioxidants.
Tamura K; Kato Y; Ishikawa A; Kato Y; Himori M; Yoshida M; Takashima Y; Suzuki T; Kawabe Y; Cynshi O; Kodama T; Niki E; Shimizu M
J Med Chem; 2003 Jul; 46(14):3083-93. PubMed ID: 12825946
[TBL] [Abstract][Full Text] [Related]
26. Hypolipidemic substituted 1,3-benzodioxole-2-carboxylates.
Grisar JM; Claxton GP; Parker RA; Palopoli FP; Kariya T
J Med Chem; 1974 Jul; 17(7):721-5. PubMed ID: 4836402
[No Abstract] [Full Text] [Related]
27. Mode of action of sesame lignans in protecting low-density lipoprotein against oxidative damage in vitro.
Kang MH; Naito M; Sakai K; Uchida K; Osawa T
Life Sci; 2000; 66(2):161-71. PubMed ID: 10666012
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of 2,3-dihydro-1,4-benzodioxin derivatives. I. 2-substituted-5(and 6)-sulfamoyl-2,3-dihydro-1,4-benzodioxins.
Itazaki H; Kawasaki A; Matsuura M; Ueda M; Yonetani Y; Nakamura M
Chem Pharm Bull (Tokyo); 1988 Sep; 36(9):3387-403. PubMed ID: 3240535
[No Abstract] [Full Text] [Related]
29. Synthesis and evaluation of N-substituted indole-3-carboxamide derivatives as inhibitors of lipid peroxidation and superoxide anion formation.
Olgen S; Varol P; Coban T; Nebioğlu D
J Enzyme Inhib Med Chem; 2008 Jun; 23(3):334-40. PubMed ID: 18569336
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of trimethylhydroquinone derivatives as anti-allergic agents with anti-oxidative actions.
Kawasaki N; Miyataka H; Nishiki M; Matsumoto H; Inagaki N; Nagai H; Satoh T
Chem Pharm Bull (Tokyo); 1999 Feb; 47(2):177-81. PubMed ID: 10071852
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of 2,3-dihydro-1,4-benzodioxin derivatives. II. 5(or 6)-acyl 2,3-dihydro-1,4-benzodioxin derivatives: new phenoxyacetic acid diuretics.
Itazaki H; Hayashi K; Matsuura M; Yonetani Y; Nakamura M
Chem Pharm Bull (Tokyo); 1988 Sep; 36(9):3404-32. PubMed ID: 3240536
[No Abstract] [Full Text] [Related]
32. Folate: in vitro and in vivo effects on VLDL and LDL oxidation.
McEneny J; Couston C; McKibben B; Young IS; Woodside JV
Int J Vitam Nutr Res; 2007 Jan; 77(1):66-72. PubMed ID: 17685097
[TBL] [Abstract][Full Text] [Related]
33. Calcium antagonist and antiperoxidant properties of some hindered phenols.
Sgaragli GP; Valoti M; Gorelli B; Fusi F; Palmi M; Mantovani P
Br J Pharmacol; 1993 Sep; 110(1):369-77. PubMed ID: 7693283
[TBL] [Abstract][Full Text] [Related]
34. Studies on hypolipidemic agents. I. Synthesis of 1,3-dioxolanes and 1,3-dioxanes.
Eriguchi A; Takegoshi T
Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):428-39. PubMed ID: 7094144
[No Abstract] [Full Text] [Related]
35. Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein.
Rojstaczer N; Triggle DJ
Biochem Pharmacol; 1996 Jan; 51(2):141-50. PubMed ID: 8615882
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic, LDL-oxidation and antioxidant activity.
Pandeti S; Sonkar R; Shukla A; Bhatia G; Tadigoppula N
Eur J Med Chem; 2013 Nov; 69():439-48. PubMed ID: 24090915
[TBL] [Abstract][Full Text] [Related]
37. Syntheses and biological evaluation of 3-substituted amino-1-aryl-6-hydroxy-hex-2-ene-1-ones as antioxidant and hypolipidemic agents.
Batra S; Srivastava S; Singh K; Chander R; Khanna AK; Bhaduri AP
Bioorg Med Chem; 2000 Aug; 8(8):2195-209. PubMed ID: 11003164
[TBL] [Abstract][Full Text] [Related]
38. Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation.
Yoshioka T; Fujita T; Kanai T; Aizawa Y; Kurumada T; Hasegawa K; Horikoshi H
J Med Chem; 1989 Feb; 32(2):421-8. PubMed ID: 2913302
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin.
Mahabusarakam W; Proudfoot J; Taylor W; Croft K
Free Radic Res; 2000 Nov; 33(5):643-59. PubMed ID: 11200095
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein.
Yamamoto N; Moon JH; Tsushida T; Nagao A; Terao J
Arch Biochem Biophys; 1999 Dec; 372(2):347-54. PubMed ID: 10600174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
